Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/2LB stock hub

FRA/2LB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/2LBis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.4B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/2LBFRA/2LB
Loading chart…
In the news

Latest news · FRA/2LB

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-47.5
P25 n/aP50 n/aP75 n/a
ROIC-28.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/2LB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
166
Groups with data
11
Currency
USD
Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
975
Employees Change
281%
Employees Change Percent
50.45
Enterprise value
EUR 1.1B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 1.4B
Price
EUR 3
Price currency
EUR
Rev Per Employee
254,059.3x
Sic
2836
Symbol
fra/2LB
Website
https://www.iovance.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-22.35%
EV Earnings
-3.74x
EV/FCF
-4.34x
EV/Sales
4.73x
FCF yield
-19.26%
P/B ratio
2.19x
P/S ratio
5.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
-125.36%
EBITDA Margin
-112.61%
Gross margin
39.44%
Gross Profit
EUR 97.7M
Gross Profit Growth
34.13%
Gross Profit Growth Q
337.77%
Net Income
EUR -306.9M
Pretax Margin
-124.21%
Profit Margin
-123.9%
Profit Per Employee
EUR -314,772
ROA
-23.65
Roa5y
-31.74
ROCE
-44.97
ROE
-47.51
Roe5y
-63.81
ROIC
-28.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr10y
-4.03%
Cagr1y
8.04%
Cagr3y
-21.28%
Cagr5y
-33.85%
Revenue Growth
34.29x
Revenue Growth Q
44.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 0.3
Assets
EUR 802.8M
Cash
EUR 271.8M
Current Assets
EUR 395.6M
Current Liabilities
EUR 109.7M
Debt
EUR 41.4M
Debt Equity
EUR 0.07
Debt FCF
EUR -0.16
Equity
EUR 626M
Liabilities
EUR 176.9M
Long Term Assets
EUR 407.3M
Long Term Liabilities
EUR 67.1M
Net Cash
EUR 230.4M
Net Cash By Market Cap
EUR 16.78
Net Cash Growth
-13.18%
Net Debt Equity
EUR -0.37
Tangible Book Value
EUR 392.6M
Tangible Book Value Per Share
EUR 0.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.6
Inventory Turnover
2.79
Net Working Capital
EUR 23.9M
Quick ratio
3.05
Working Capital
EUR 292.4M
Working Capital Turnover
EUR 0.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-25.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-33.75%
1Y total return
8.03%
200-day SMA
2.36
3Y total return
-51.22%
50-day SMA
3.27
50-day SMA vs 200-day SMA
50over200
5Y total return
-87.33%
All Time High
43.46
All Time High Change
-93.1%
All Time High Date
2021-01-14
All Time Low
1.43
All Time Low Change
109.64%
All Time Low Date
2025-07-08
ATR
0.14
Ch YTD
28.15
High
3.13
High52
4.75
High52 Date
2026-03-10
High52ch
-36.78%
Low
3
Low52
1.43
Low52 Date
2025-07-08
Low52ch
109.64%
Ma50ch
-8.12%
Price vs 200-day SMA
26.9%
RSI
47.2
RSI Monthly
43.17
RSI Weekly
53.9
Sharpe ratio
1.06x
Sortino ratio
2.02
Total Return
-25.4%
Tr YTD
28.18
Tr1m
7.34%
Tr1w
1.87%
Tr3m
53.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -310.5M
Operating margin
-125.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
353,452,525%
Shares Insiders
6.62%
Shares Institutions
53.18%
Shares Qo Q
2.84%
Shares Yo Y
25.4%
Short Ratio
6.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
EUR -307.8M
Average Volume
502.1x
Bv Per Share
1.43
CAPEX
EUR -29.7M
Ch10y
-33.75
Ch1m
7.34
Ch1w
1.87
Ch1y
8.03
Ch3m
53.14
Ch3y
-51.22
Ch5y
-87.33
Ch6m
63.93
Change
-13.04%
Change From Open
0
Close
3.45
Days Gap
-13.04
Depreciation Amortization
30,876,840.3
Dollar Volume
4,116
Earnings Date
2026-05-07
EBIT
EUR -310.5M
EBITDA
EUR -278.9M
EPS
EUR -0.8
F Score
2
FCF
EUR -264.5M
FCF EV Yield
-23.05x
Financing CF
218,380,069
Fiscal Year End
December
Founded
2,007
Income Tax
EUR -778,835
Investing CF
37,313,848
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
2.45
Ma150ch
22.55%
Ma20
3.09
Ma20ch
-3.01%
Net CF
21,206,352
Open
3
Position In Range
0
Ppne
149,051,368.5
Price Date
2026-05-08
Ptbv Ratio
3.5
Relative Volume
2.88x
Revenue
247,707,818x
SBC By Revenue
17.48x
Share Based Comp
43,303,422
Tax By Revenue
-0.31x
Tr6m
63.93%
Volume
1,372
Z Score
-2.04
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/2LB pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2LB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+8.0%
S&P 500 1Y: n/a
3Y total return
-51.2%
S&P 500 3Y: n/a
5Y total return
-87.3%
S&P 500 5Y: n/a
10Y total return
-33.7%
S&P 500 10Y: n/a
Ownership

Who owns FRA/2LB?

Insider, institutional, and short-interest positioning.

Institutional ownership
+53.2%
Share of float held by funds and institutions
Insider ownership
+6.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
6.5 days to cover
Y/Y dilution
+25.4%
Negative means the company is buying back shares.
Technical

FRA/2LB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.2
Neutral momentum band
Price vs 200-day MA
+26.9%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.06
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/2LB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2LB stock rating?

fra/2LB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2LB analysis?

The full report lives at /stocks/fra/2LB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2LB?

The latest report frames fra/2LB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2LB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/2LB stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario